Zomedica Highlights the Data of TRUFORMA Research to Diagnose Thyroid Disease in Cats at ACVIM 2024
Shots:
- Zomedica highlighted diagnostic abilities of the TRUFORMA Bulk Acoustic Wave (BAW) platform vs chemiluminescent immunoassay (CLIA) platforms in a presentation entitled, 'Evaluation of a Feline-Optimized TSH Assay in Cats with Hyperthyroidism and with Non-Thyroidal Illness'
- The research showed the system’s sensitivity at low ranges & ability to accurately diagnose hyperthyroidism in cats with confounding non-thyroid illness (NTI)
- The platform uses BAW technology for precise & sensitive measurements plus enables diagnosis & treatment of complex thyroid & adrenal conditions, canine non-infectious gastrointestinal disease as well as equine Cushing's disease by generating accurate, fast & reliable data
Ref: Zomedica | Image: Zomedica
Related News:- Zomedica Launches Truforma Diagnostic Platform for Diagnosis and Management of Cushing’s Disease in Horses
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
